Cambium Bio Limited has released a press release.
Regeneus receives A$1.6M milestone payment from Kyocera
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Cambium Bio
- Regeneus signs MOU with Kyocera Corporation
- Half-Year Results & Business Update
- Directors provide $4m loan facility
- AGC Agreement termination paves way for commercial partner
- CEO Presentation to 2019 Annual General Meeting
Later from Cambium Bio
- Regeneus to be granted new key Progenza patent in U.S.
- Appendix 4C Updated
- Kyocera completes Progenza Due Diligence
- Progenza OA Kyocera negotiations update
- Regeneus and Kyocera sign Progenza OA deal
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio